Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

This decision, described by CEO Anne Wojcicki as “difficult but necessary,” comes as the genetic testing company undergoes a ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

But in announcing the cuts, 23andMe CEO Anne Wojcicki said her goal is to ensure the "long-term success" of its core consumer ...

As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...